Sage Journals: Discover world-class research

Free access

Brief report

First published 2007-6

Pharmacokinetic Enhancement of the Hepatitis C Virus Protease Inhibitors VX-950 and SCH 503034 by Co-Dosing with Ritonavir

Dale J Kempf, Cheri Klein, Hui-Ju Chen [...]

Antiviral Chemistry and Chemotherapy

Retricted access

Research article

First published 2007-02

Dose reduction effective in alleviating symptoms of saquinavir toxicity

International Journal of STD & AIDS

Free access

Research article

First published 2006-1

Ritonavir-Boosted Atazanavir-Lopinavir Combination: A Pharmacokinetic Interaction Study of Total,Unbound Plasma and Cellular Exposures

Sara Colombo, Thierry Buclin, Claudia Franc [...]

Antiviral Therapy

Free access

Review article

First published 2018-6

Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia

Massimo Morfini, Stefano Gherardini

Therapeutic Advances in Hematology

Free access

Research article

First published 2015-7

A Pharmacokinetic/Viral Kinetic Model to Evaluate the Treatment Effectiveness of Danoprevir against Chronic HCV

Laetitia Canini, Anushree Chatterjee, Jeremie Guedj [...]

Antiviral Therapy

Free access

Announcement

First published 2018-11

Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults

HIV-NAT 223 study team, Akarin Hiransuthikul, Narukjaporn Thammajaruk [...]

Antiviral Therapy

Open access

Research article

First published 2022

Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study)

Céleste J.T. van der Togt, Lise M. Verhoef, Bart J.F. van den Bemt [...]

Therapeutic Advances in Musculoskeletal Disease

Search results

Pharmacokinetic Enhancement of the Hepatitis C Virus Protease Inhibitors VX-950 and SCH 503034 by Co-Dosing with Ritonavir

Dose reduction effective in alleviating symptoms of saquinavir toxicity

Ritonavir-Boosted Atazanavir-Lopinavir Combination: A Pharmacokinetic Interaction Study of Total,Unbound Plasma and Cellular Exposures

Pharmacokinetic-based prediction of real-life dosing of extended half-life clotting factor concentrates on hemophilia

A Pharmacokinetic/Viral Kinetic Model to Evaluate the Treatment Effectiveness of Danoprevir against Chronic HCV

Pharmacokinetics and 48-week safety and efficacy of generic ritonavir tablet-boosted atazanavir in HIV-1-infected Thai adults

Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study)